All news

Leerink lifts IQVIA price target to $310

Alpha Vantage · www.marketscreener.com · · AI-summarised by FinFlash

Leerink Partners raised its price target on IQVIA Holdings to $310 from $280, keeping a bullish view on the healthcare analytics and contract research company. The revision adds to a series of analyst target changes for IQVIA. The average analyst target stands at $290.84 versus a share price of $258.11, implying roughly 12.7% upside. Analyst ratings on the stock total 19 Buy, 3 Hold and 0 Sell.

Read original source

IQV company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.